(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS Biologics won an award at the 2020 BioChallenge

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-12-02 17:38
  • 조회 : 357회

본문


30 November 2020

 

ILIAS Biologics won an award at the 2020 BioChallenge 

 

On November 30th, ILIAS Biologics received the ‘Cytiva Korea CEO Award' at the 2020 BioChallenge. The 2020 BioChallenge, hosted by Maeil Business News Korea, sponsored by Cytiva(formerly GE Healthcare Life Sciences), selected the seven promising Korean biotech and pharmaceutical companies.

 

ILIAS is entitled to receive (1) APAC Fast Trak Training and (2) products for cell culture and purification worth up to 150 million Korean won as the benefit of the award. ILIAS will accelerate its scaled-up manufacturing process development of exosome-based therapeutics with this benefit and support.

 

Please find the link below for more information.

 

(Kor)

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기